Use of daily vitamin K supplementation in patients on warfarin with a history of frequent dose changes or variable INRs

被引：0
|
作者：
S. K. Ford
C. P. Misita
B. B. Shilliday
R. M. Malone
S. Moll
机构：
[1] University of North Carolina,
来源：
Journal of Thrombosis and Thrombolysis | 2008年 / 25卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：94 / 94
相关论文
共 50 条
  • [41] Anticoagulation for Noncardiac Indications in Neurologic Patients: Comparative Use of Non-Vitamin K Oral Anticoagulants, Low-Molecular-Weight Heparins, and Warfarin
    Ariela L. Marshall
    Jean-Marie Connors
    Current Treatment Options in Neurology, 2014, 16
  • [42] Anticoagulation for Noncardiac Indications in Neurologic Patients: Comparative Use of Non-Vitamin K Oral Anticoagulants, Low-Molecular-Weight Heparins, and Warfarin
    Marshall, Ariela L.
    Connors, Jean-Marie
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2014, 16 (09)
  • [43] Comparison of the Efficacy and Safety of Non-vitamin K Antagonist Oral Anticoagulants with Warfarin in Atrial Fibrillation Patients with a History of Bleeding: A Systematic Review and Meta-Analysis
    Suah, Boon-Hao
    Lee, Zhi-Yan
    Teo, Yao Hao
    Teo, Yao Neng
    Syn, Nicholas L. X.
    Soh, Rodney Y. H.
    Yeo, Leonard L. L.
    Tan, Benjamin Y. Q.
    Ho, Jamie Sin-Ying
    Li, Tony Y. W.
    Lee, Chi-Hang
    Chan, Mark Y.
    Yeo, Tiong-Cheng
    Wong, Raymond C. C.
    Chai, Ping
    Sia, Ching-Hui
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2022, 22 (05) : 511 - 521
  • [44] Comparison of the Efficacy and Safety of Non-vitamin K Antagonist Oral Anticoagulants with Warfarin in Atrial Fibrillation Patients with a History of Bleeding: A Systematic Review and Meta-Analysis
    Boon-Hao Suah
    Zhi-Yan Lee
    Yao Hao Teo
    Yao Neng Teo
    Nicholas L. X. Syn
    Rodney Y. H. Soh
    Leonard L. L. Yeo
    Benjamin Y. Q. Tan
    Jamie Sin-Ying Ho
    Tony Y. W. Li
    Chi-Hang Lee
    Mark Y. Chan
    Tiong-Cheng Yeo
    Raymond C. C. Wong
    Ping Chai
    Ching-Hui Sia
    American Journal of Cardiovascular Drugs, 2022, 22 : 511 - 521
  • [45] Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants versus warfarin in non-valvular atrial fibrillation patients: the dose subgroup analysis of the ARISTOPHANES study
    Deitelzweig, S.
    Keshishian, A.
    Li, X.
    Hamilton, M.
    Masseria, C.
    Dhamane, A.
    Luo, X.
    Mardekian, J.
    Friend, K.
    Nadkarni, A.
    Pan, X.
    Baser, O.
    Lip, G. Y. H.
    EUROPEAN HEART JOURNAL, 2018, 39 : 610 - 611
  • [46] Comparative Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Non-valvular Atrial Fibrillation Patients: The Dose Subgroup Analysis of the ARISTOPHANES Study
    Deitelzweig, Steve
    Keshishian, Allison
    Li, Xiaoyan
    Hamilton, Melissa
    Masseria, Cristina
    Dhamane, Amol
    Luo, Xuemei
    Mardekian, Jack
    Friend, Keith
    Nadkarni, Anagha
    Pan, Xianying
    Baser, Onur
    Lip, Gregory
    NEUROLOGY, 2019, 92 (15)
  • [47] Changes in primary care management of atrial fibrillation patients following the shift from warfarin to non-vitamin K antagonist oral anticoagulants: a Norwegian population based study
    Sigrun Halvorsen
    Jørgen Anton Smith
    Fabian Söderdahl
    Marcus Thuresson
    Oddvar Solli
    Maria Ulvestad
    Christian Jonasson
    BMC Primary Care, 23
  • [48] Changes in primary care management of atrial fibrillation patients following the shift from warfarin to non-vitamin K antagonist oral anticoagulants: a Norwegian population based study
    Halvorsen, Sigrun
    Smith, Jorgen Anton
    Soderdahl, Fabian
    Thuresson, Marcus
    Solli, Oddvar
    Ulvestad, Maria
    Jonasson, Christian
    BMC PRIMARY CARE, 2022, 23 (01):
  • [49] Outcomes After Use of Standard- and Low-Dose Non-Vitamin K Oral Anticoagulants in Asian Patients With Atrial Fibrillation
    Cho, Min Soo
    Yun, Ji Eun
    Park, Ji Jeong
    Kim, Yun Jung
    Lee, Jessie
    Kim, Hyungmin
    Park, Duk-Woo
    Nam, Gi-Byoung
    STROKE, 2019, 50 (01) : 110 - 118
  • [50] Warfarin dose requirement and cytochrome P450 2C9 and Vitamin K epoxide reductase complex subunit 1-1639 genetic polymorphisms in Thai patients
    Subsuphan, Burassakorn
    Chinpaisal, Chatchai
    Pongchaidecha, Manat
    Phanthabordeekorn, Wibun
    Watana, Surawut
    ARCHIVES OF PHARMACY PRACTICE, 2016, 7 (01) : 18 - 25
12345